Capital Research takes 5.3% stake in Quantinuum
Capital Research Global Investors, a division of Capital Research and Management Company and its investment management affiliates, reported beneficial ownership of 1,754,325 shares of Quantinuum Inc. common stock.
Rhea-AI Filing Summary
Capital Research Global Investors, a division of Capital Research and Management Company and its investment management affiliates, reported beneficial ownership of 1,754,325 shares of Quantinuum Inc. common stock. This represents 5.3% of the 32,862,895 shares believed to be outstanding.
Capital Research Global Investors reports sole voting and dispositive power over all 1,754,325 shares, with no shared voting or dispositive power.
Key Figures
Key Terms
beneficial owner financial
sole voting power financial
sole dispositive power financial
Schedule 13G regulatory
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Quantinuum Inc. (QNT) does Capital Research Global Investors own?
What type of filing discloses Capital Research Global Investors’ stake in Quantinuum Inc. (QNT)?
Who signed the Quantinuum Inc. (QNT) Schedule 13G for Capital Research Global Investors?
AI-generated analysis. How Rhea-AI works. Not financial advice.